Author: openjargon

CSL Ltd (ASX: CSL) shares have surged 23% across the past two trading days to $166.48, lifting their monthly gain to 34%.

After plunging from $228.30 in October to a low of $90, the recovery is gathering serious pace. Yet CSL remains down 4% year to date and 32% over 12 months.

Can the rebound last?

Why are CSL shares surging?

The big catalyst was CSL’s FY26 result, released on Tuesday.

At first glance, the numbers looked ugly. CSL reported a US$2.6 billion net loss after tax. But that loss wasn’t an operating disaster.

It reflected US$7.1 billion of pre-tax impairments and another US$799 million in restructuring costs, largely non-cash. Most of the impairments related to CSL Vifor intangibles and under-utilised property, plant and equipment.

Investors had already been warned. In May, CSL flagged roughly US$5 billion of impairments and cut its FY26 guidance.

Strip away those exceptional items and the picture looks much healthier. Underlying NPATA came in at US$3.1 billion, down just 2%, while revenue slipped 1% to US$15.8 billion — still ahead of analyst expectations.

That gave investors in CSL shares something they had been waiting for: a reset year, a cleaner balance sheet and guidance that finally beat expectations.

CSL Behring remains the powerhouse. Its plasma division generated US$11.4 billion in revenue, down 1%, while immunoglobulin revenue held steady at US$6.2 billion. That’s crucial to the bull case.

CSL Vifor grew revenue 3% to US$2.4 billion, while Seqirus struggled, with revenue falling 8% to US$2 billion.

Meanwhile, CSL’s transformation program delivered US$176 million of cost savings, and management committed US$1.5 billion to expand US plasma collection capacity.

Guidance is driving the recovery

Here’s where things get interesting. CSL expects underlying NPAT to grow approximately 5% in FY27. Consensus had been closer to 2%.

After 18 months of downgraded expectations, that upgrade was a welcome surprise for shareholders in CSL shares. Behring is expected to deliver mid-single-digit growth, with immunoglobulins growing at a mid-to-high single-digit rate.

The weak spot remains Vifor, where revenue is expected to fall about 25% as iron generics arrive.

Are CSL shares fully valued?

Not everyone is convinced the rally can continue. Bell Potter retained its hold rating but lifted its price target from $120 to $150, suggesting CSL shares are now fully valued.

The broker said:

Based on the new underlying NPAT metric, CSL trades on a PE multiple of ~19x FY26 and ~18x FY27 earnings, with flat revenue growth and low-to-mid single digit earnings growth expected for FY27. While the result today suggests the worst (by way of earnings declines) is in the rear-view for CSL, we find it difficult to justify a greater premium than is now being attributed relative to global biopharma peers.

So, while CSL’s recovery looks encouraging, the shares have already priced in plenty of optimism. The next challenge is proving that earnings growth can accelerate enough to justify the rally.

The post CSL shares are flying higher. Is it too late to buy? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: BHP, CSL, and HUB24 shares
• How much are CSL shares worth? 4 brokers have their say
• 3 ASX 200 shares I’d buy for the next decade
• Here are the top 10 ASX 200 shares today
• CSL shares: 1 number that investors shouldn’t ignore

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Dexus (ASX: DXS) share price is in focus today after the company reported FY26 results featuring adjusted funds from operations (AFFO) of $483.9 million and distributions of 37.0 cents per security, both matching previous guidance. Statutory net profit after tax was $482.2 million, and gearing remained at the lower end of the group’s target range.

What did Dexus report?

• Statutory net profit after tax of $482.2 million (up from $136.1 million in FY25)
• Adjusted funds from operations (AFFO) steady at $483.9 million
• Distribution per security maintained at 37.0 cents
• Gearing (look-through) at 33.4%, providing balance sheet flexibility
• Office occupancy 95.7%, well above the market average of 85.1%
• Industrial effective like-for-like income growth of 8.3%

What else do investors need to know?

Dexus reported continued strength in its core office and industrial portfolios, with both segments outperforming broader market trends. The group successfully secured around $2 billion in third-party equity commitments and completed more than $1.9 billion in divestments, exceeding its divestment target for FY25–FY27.

A strategic review of the infrastructure funds business is underway after legal proceedings relating to the APAC airports matter. Dexus has provided for legal costs and is in regular consultation with investors regarding the future of certain funds. Major developments like Atlassian Central remain on schedule, while the Waterfront Brisbane project is facing a delay to late 2029.

What’s next for Dexus?

Looking to FY27, Dexus expects lower earnings due to reduced performance fees, an immaterial contribution from trading profits, and a smaller contribution from funds under review. The company targets AFFO of 37.5–39.5 cents per security and distributions maintained at 37.0 cents per security, assuming no major changes in market conditions.

Strategic priorities for the year ahead include completing the Atlassian Central project, further capital recycling, broadening capital partnerships, and enhancing platform efficiency. Dexus also aims to continue simplifying its fund offering and embed new technologies for greater operational efficiency.

Dexus share price snapshot

Over the past 12 months, the Dexus share price has underperformed the S&P/ASX 200 index (ASX: XJO) with a disappointing decline of 22%. This reflects sector headwinds and uncertainty over the funds management division.

View Original Announcement

The post Dexus delivers steady FY26 results, maintains distributions, and advances strategy appeared first on The Motley Fool Australia.

More reading

• How much superannuation is needed to target $8,000 per month in passive income?
• Rotating into dividend shares? 3 of your best options right now with yields as high as 9%
• Buy, hold, sell: Dexus, Origin Energy, Magellan shares
• 1 ASX dividend stock down 46% I’d buy right now
• How much is needed in superannuation to target a $12,000 monthly passive income?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Codan Ltd (ASX: CDA) share price is in focus today after the company delivered a 30% jump in annual revenue to $875 million and a 69% rise in net profit after tax to $175.2 million for FY26.

What did Codan report?

• Revenue up 30% to $874.97 million
• Net profit after tax (NPAT) up 69% to $175.18 million
• EBIT up 67% to $244.08 million
• Fully franked full-year dividend of 48.5 cents per share (up 70% on FY25)
• Net cash position of $35.7 million at 30 June 2026
• Earnings per share up 69% to 96.5 cents

What else do investors need to know?

Codan’s Communications business (including DTC and Zetron) reported revenue of $506.2 million, up 22%, with segment profit up 45% and margins beating long-term targets. The order book jumped 50% to $380 million, underpinned by momentum in unmanned radio systems and strong defence demand.

Minelab, the company’s Metal Detection division, achieved record results, with revenue rising 42% to $362 million and segment profit up 65%. New product launches, like the flagship GPZ8000 gold detector, helped drive growth, particularly in Africa and the rest of the world.

Codan also completed the acquisition of US-based Adaptive Dynamics after year-end, further strengthening its technical offerings for defence customers. Codan finished FY26 with a solid net cash position and significant undrawn debt facilities, giving the board flexibility for future investment and growth initiatives.

What’s next for Codan?

For FY27, Codan is targeting revenue growth of around 20%, supported by high defence spending and continued demand for both unmanned communications systems and advanced gold detectors. A full-year contribution from recently launched Minelab products and new client wins in Communications are expected to underpin momentum.

The company says it will continue investing in people, systems, and new product development, with an eye for further acquisitions aligned with its technology and market strategy. The board is optimistic about ongoing growth opportunities and plans to update investors further at the annual general meeting in October.

Codan share price snapshot

Over the past 12 months, Codan shares have surged 84%, significantly outpacing the S&P/ASX 200 Index (ASX: XJO).

View Original Announcement

The post Codan FY26: Profit surges 69% with higher dividend appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• ASX 200 tech shares lead again as big US earnings inspire local confidence

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Bega Cheese Ltd (ASX: BGA) share price is in focus today after the company posted a strong FY2026, with statutory EBITDA up 22% to $202.3 million and revenue climbing 7% to $3.77 billion.

What did Bega Cheese report?

• Revenue rose 6.7% to $3,774.6 million
• Statutory EBITDA jumped 22% to $202.3 million
• Statutory profit after tax reached $54.8 million, up from a loss last year
• Normalised EBITDA increased 12% to $225.6 million
• Final fully franked dividend of 7.5 cents per share, bringing total FY2026 dividends to 14.5 cents per share
• Net debt increased to $151.6 million due to capital investment and restructuring

What else do investors need to know?

Bega Cheese’s Branded segment saw solid growth from strong sales of yoghurt, milk beverages, and international revenues. Higher demand for protein and health-focused products, plus cost savings from exiting primary peanut processing, helped boost results.

In the Bulk segment, improved integration of ingredients into the branded range and better commodity conditions lifted performance. The group also completed warehouse automation and consolidated cheese packaging operations, aiming for further efficiency.

What’s next for Bega Cheese?

Bega has refreshed its strategy, targeting more than $310 million in normalised EBITDA by FY2031. Investment in marketing and automation is expected to drive continued growth in core dairy and better-for-you products.

Management has provided normalised EBITDA guidance in the range of $240–$245 million for FY2027, supported by ongoing demand for protein and strong international sales, particularly in Southeast Asia.

Bega Cheese share price snapshot

Bega Cheese’s share price has outperformed the S&P/ASX 200 Index (ASX: XJO) in the past year with a gain of 15%, reflecting resilient demand for its key products.

View Original Announcement

The post Bega Cheese defies headwinds with strong FY26 results and upbeat outlook appeared first on The Motley Fool Australia.

More reading

• MA Financial delivers record 1H26 earnings and lifts dividend
• Sonic Healthcare share price in focus on FY26 profit jump and digital push
• Ridley: FY26 profit jumps on fertiliser boost
• IPH Ltd FY26 earnings: resilient profit growth and higher dividend
• 2 ASX shares tipped to grow 40% or more in the next 12 months

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Cuscal Ltd (ASX: CCL) share price is in focus today after reporting a 49% jump in statutory NPAT to $42.7 million for FY26, boosted by acquisitions of Indue and Paymark.

What did Cuscal report?

• Statutory net profit after tax (NPAT) up 49% to $42.7 million
• Underlying NPAT up 20% to $46.2 million
• Underlying net operating income rose 20% to $347.7 million
• Aggregate transaction volumes grew 12% over the year
• Final dividend of 7.0 cents, taking the full year dividend to 11.5 cents per share
• Indue and Paymark acquisitions contributed $34.8 million and $5.2 million respectively to net operating income

What else do investors need to know?

Cuscal completed the acquisition of Indue in December 2025 and Paymark in May 2026, both adding scale and new capabilities to the business. The company removed one-off costs from its underlying profit figure, including integration expenses and fair value adjustments, making it easier for investors to gauge the real health of the business.

The group’s strong capital position underpins its dividend payout and supports future investment. Conference call and webcast details for investors are available for those wanting more information about the result and company outlook.

What did Cuscal management say?

Managing Director Craig Kennedy said:

FY26 was a defining year for Cuscal. The acquisitions of Indue and Paymark have significantly increased our scale, strengthened our position across Australia and New Zealand, and expanded the range of payments capabilities we deliver to clients. These acquisitions were completed against a backdrop of continued growth across our core business. As we enter FY27, our focus is on supporting client growth, progressing integration, delivering synergies, and executing on the opportunities created by bringing these businesses together.

What’s next for Cuscal?

Looking ahead, Cuscal expects another year of strong growth in FY27, targeting mid-twenties percentage increases for both transaction volumes and underlying NPAT. Management says the integration of Indue and Paymark is expected to support further synergies and scale benefits.

Cuscal remains focused on supporting client growth and delivering value, including bringing new products and services to clients across Australia and New Zealand. The company aims to build on its recent acquisitions, drive innovation, and maintain disciplined cost management.

Cuscal share price snapshot

Over the past 12 months, Cuscal shares have risen 79%, significantly outperforming the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post Cuscal FY26 earnings: Profit jumps 49% on Indue & Paymark deals appeared first on The Motley Fool Australia.

More reading

• MA Financial delivers record 1H26 earnings and lifts dividend
• Sonic Healthcare share price in focus on FY26 profit jump and digital push
• Ridley: FY26 profit jumps on fertiliser boost
• IPH Ltd FY26 earnings: resilient profit growth and higher dividend
• 2 ASX shares tipped to grow 40% or more in the next 12 months

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Zip Co Ltd (ASX: ZIP) share price is in focus today after the company posted record FY26 cash EBTDA of $268.9 million, up 57.9%, and a material increase in net profit after tax to $116.4 million, up 45.7% on the prior year.

What did Zip Co Limited report?

• Record cash EBTDA of $268.9 million, up 57.9% vs FY25
• Total revenue rose 24.7% to $1,336.1 million
• Operating margin expanded to 20.0%, from 15.8% last year
• Total transaction volume (TTV) increased 27.2% to $16.7 billion
• Net profit after tax of $116.4 million, up 45.7%
• Active customers grew to 6.5 million, a 3.7% lift year on year

What else do investors need to know?

Zip continued to deliver strong growth in the US, with total transaction volume and revenue up over 42% in local currency. In Australia and New Zealand, the company reported improved revenue and Australian receivables growth, led by its Zip Plus product, while announcing a wind down of its New Zealand operations to sharpen focus on Australia.

The business strengthened its funding platforms with new note issuances and warehouse facilities, increasing available cash and liquidity to $246.5 million. Zip also completed $150 million of share buybacks and announced a further on-market buyback of up to $50 million for FY27.

Looking ahead, Zip is considering a share consolidation to reduce the number of shares on issue and is exploring the possibility of a dual listing on a US stock exchange, should market conditions support this.

What did Zip Co management say?

Zip Group CEO and Managing Director, Cynthia Scott, said:

Consistent execution has built the platform to deliver our next phase of growth and innovation. In FY26, we exceeded our targets with record cash earnings of $268.9m, up 57.9%, underpinned by material cash earnings growth in both markets. We maintained strong unit economics, expanded operating leverage and reinforced the value of our differentiated business model.

Our focus on exceptional customer experiences is translating into stronger engagement. In the US, we achieved more than 40% growth in both TTV and revenue for a second consecutive year while adding new customers at scale. In ANZ, we returned to revenue and Australian receivables growth, led by the continued success of our Zip Plus product.

We delivered strong credit outcomes, strengthened our funding platforms and embedded AI across our people, processes and products. We also returned $150 million to shareholders through share buybacks and continue to optimise our capital structure, with new capital management initiatives announced today. Looking ahead, we are focused on executing on our FY27 strategic priorities to drive growth and innovation, and investing for long-term scale.

What’s next for Zip Co?

Looking forward, Zip aims to deliver group cash EBTDA of $340 million in FY27, up 26% on FY26, while targeting an operating margin of 20%–22%. US transaction volume is expected to grow by more than 30% (in USD), with a group revenue margin around 8%.

Management says it remains committed to scaling through further product innovation, AI integration, and capital management initiatives. Investors can also expect ongoing updates on potential share consolidation plans and any move towards a US dual listing.

Zip Co share price snapshot

The Zip Co share price has underperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a decline of around 15%.

View Original Announcement

The post Zip Co reports record FY26 earnings and outlines growth strategy appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• Xero vs Zip shares: Which ASX 200 tech stock has made investors richer over the past month?
• Zip shares are getting crushed: What’s gone wrong?
• Should I buy Block and Zip shares in August?
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Owners of ANZ Group Holdings Ltd (ASX: ANZ) shares may not have seen a lot of net profit growth over the past decade, but investors may like to know what analysts are expecting of the ASX bank share in the coming two annual results and how that plays into the valuation.

Profit growth is not guaranteed, of course, but ANZ is facing somewhat challenging conditions, with loan demand facing headwinds amid taxation changes and higher interest rates.

But, at the same time, borrowers may be less reliable during this period of economic uncertainty and higher interest rates.

Despite that, shareholders will be pleased to know that the ASX bank share is predicted to grow earnings in the coming annual FY26 result. A projection is not a guarantee of growth, though.

FY26

The ASX bank share’s 2026 financial year finishes in September 2026, so there is still more than a month to go for ANZ.

But, the latest update from the bank showed further progress by the business.

Its quarterly cash profit of $1.9 billion showed 2% year-over-year growth. Net loans and advances were flat year-over-year at $846 billion, though there was an increase in constant currency terms.

The bank also reported that its cost-to-income ratio improved by 155 basis points (1.55%) year-over-year to 49.66%.

ANZ won’t be able to cut costs every reporting period to grow earnings, but it made a sizeable difference in the FY26 third quarter. Operating income for the bank actually declined by 1% year-over-year, while operating expenses improved by 4%. That helped profit before provisions increase 3% to $2.8 billion.

It was a 6% rise in the provision charge to $102 million and a 4% rise in the income tax expense to $819 million that meant the cash profit growth was slower than the profit before provisions growth. Profit is important for supporting ANZ shares.

Analysts expect the ASX bank share’s earnings per share (EPS) to rise to $2.566 in the 2026 financial year, according to Commsec.

FY27

There are a number of things that ANZ is working on to improve its operations in the coming years, including in FY27.

First, ANZ wants to embed its new leadership team and continue to drive a cultural reset.

Second, the ASX bank share wants to integrate Suncorp Bank faster to deliver value.

Third, ANZ wants to accelerate the delivery of its single customer digital front-end.

Fourth, it wants to reduce duplication and simplify the organisation. It noted that 84% of 3,500 announced roles exited the bank by the end of June 2026. Around of 73% of estimated gross cost savings of $875 million in FY26 were realised by the end of June 2026.

Fifth, it wants to enhance non-financial risk management to improve the ASX bank share’s resilience.

The projection on Commsec suggests the business could see EPS slightly fall to $2.55 in FY27.

Therefore, ANZ’s profit isn’t likely to do much after FY26, so there could be better ASX shares to consider.

The post Here’s the earnings forecast out to 2027 for ANZ shares appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: ANZ Bank, Iress, and JB Hi-Fi shares
• Buy, hold, sell: Aristocrat, Telstra, ANZ shares
• These ASX 200 shares could generate $10,000 per year in passive income
• Why I’d buy these 2 ASX ETFs for $10,000 a year in passive income
• 8 ASX 200 shares with fresh buy ratings this week

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company reported half-year revenue up 22% to US$477 million and a strong gross margin improvement to 55%. Adjusted EBITDA surged 146% year-on-year to US$52 million.

What did Telix Pharmaceuticals report?

• Revenue rose 22% year-on-year to US$477 million, tracking to the upper end of FY26 guidance.
• Gross margin climbed to 55%, with Precision Medicine segment margin at 65%.
• Adjusted EBITDA came in at US$52 million, up 146% on the prior year.
• Profit after tax was US$38 million, including a US$40 million payment from Regeneron.
• Group R&D investment was US$124 million, mainly supporting late-stage programs.
• Positive operating cash flow of US$23 million and cash balance of US$252 million at 30 June 2026.

What else do investors need to know?

Telix announced a new strategic collaboration with Regeneron to develop and commercialise next-generation radiopharmaceutical therapies, contributing US$40 million in other income this half. The company also completed refinancing of its convertible bond structure with a new US$600 million issue due 2031.

Operationally, the Precision Medicine segment drove growth with flagship products Illuccix and Gozellix gaining market share. Key clinical milestones were achieved, including enrolment completion for late-stage trials and regulatory progress in the US, China, Europe, and Japan. Telix is also expanding its global manufacturing footprint with new and upgraded facilities in Australia, Belgium, Japan, and the US.

What did Telix Pharmaceuticals management say?

Managing Director and Group CEO, Dr Christian Behrenbruch, said:

Telix delivered an outstanding first half, with strong revenue growth, market share gains and significant progress across clinical and regulatory milestones. Our strengthened balance sheet is enabling increased investment in late-stage programs, including ProstACT Global, market expansion opportunities within our precision medicine portfolio and manufacturing and supply chain capabilities that differentiate Telix. With multiple near-term catalysts, we enter the second half with strong momentum and confidence.

What’s next for Telix Pharmaceuticals?

Telix reaffirmed FY26 revenue and other income guidance above US$1 billion, with R&D expenditure expected between US$230 million and US$270 million. The company expects ongoing clinical trial readouts and regulatory submissions in key territories later in the year.

Strategically, Telix will leverage its expanded manufacturing capacity and commercial partnerships to support commercial growth and pipeline advancement. The new at-the-market equity facility is intended to provide flexible access to capital to underpin future expansion, subject to regulatory approvals.

Telix Pharmaceuticals share price snapshot

The Telix Pharmaceuticals share price has recorded a small decline over the past 12 months, compared with a 1.5% gain from the S&P/ASX 200 index (ASX: XJO).

View Original Announcement

The post Telix Pharmaceuticals delivers robust half-year earnings and pipeline progress appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• After rocketing 24% last week, what are experts saying about these red hot ASX shares?
• Here are the top 10 ASX 200 shares today
• Which are the 10 most shorted ASX shares?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Autosports Group Ltd (AS:X ASG) share price is in focus today after the prestige car retailer posted record full-year revenue of $3.19 billion and normalised profit before tax up 11.1%.

What did Autosports Group report?

• Record FY26 revenue of $3.19 billion, up 11.9% year on year
• Gross profit reached $589.7 million, up 15% from FY25
• Normalised NPBT of $53.5 million, up 11.1%
• New vehicle order write climbed 20% compared to the prior year
• Order bank soared 290% since 30 June 2025
• Vehicle service and parts revenue increased by 16% and 22%, respectively

What else do investors need to know?

Autosports Group’s core prestige and luxury segments stayed resilient despite challenging market conditions, supported by strong demand for new energy and electric vehicles. The group faced stock shortages in the final quarter as accelerated demand for electric models outpaced inventory, but it maintained gross margins at 18.5%.

To fund growth and expand its network, the company increased its Syndicated Facility Agreement by $85 million to $435 million, extending maturities and relaxing some covenants. Meanwhile, new greenfield dealerships are scheduled to open in Sydney, and a key property acquisition in Canberra will strengthen its ACT operations.

What did Autosports Group management say?

Chief Executive Officer Nick Pagent said:

Our record performance reflects our disciplined growth strategy and commitment to representing brands that are future-ready. The surge in electric vehicle demand puts us in a strong position as new supply arrives.

What’s next for Autosports Group?

Autosports Group remains upbeat as it enters FY27 with new dealership launches, including Mercedes-Benz Southport and new luxury EV brands Omoda Jaecoo and XPENG in Sydney. The acquisition in Canberra underpins further expansion plans.

Management expects the record order bank to begin unwinding in the second half of FY27 as new electric vehicle supply finally meets strong demand. Additional growth is anticipated from newly acquired businesses and continued roll-out of new electric and luxury vehicles, positioning Autosports Group well in the evolving automotive market.

Autosports Group share price snapshot

Over the past 12 months, Autosports Group shares have declined 46%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post Autosports Group posts record revenue and surging EV orders in FY26 appeared first on The Motley Fool Australia.

More reading

• MA Financial delivers record 1H26 earnings and lifts dividend
• Sonic Healthcare share price in focus on FY26 profit jump and digital push
• Ridley: FY26 profit jumps on fertiliser boost
• IPH Ltd FY26 earnings: resilient profit growth and higher dividend
• 2 ASX shares tipped to grow 40% or more in the next 12 months

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Fortescue Ltd (ASX: FMG) share price is in focus after the company delivered record iron ore shipments and posted a nine per cent jump in underlying EBITDA to US$8.6 billion for the year ended 30 June 2026.

What did Fortescue report?

• Revenue grew 9% to US$17.0 billion.
• Underlying EBITDA rose 9% to US$8.6 billion (margin: 51%).
• Underlying net profit after tax (NPAT) increased 3% to US$3.5 billion.
• Free cash flow up 25% to US$3.2 billion.
• Fully franked dividends for FY26 totalled A$1.08 per share (65% payout ratio).
• Net debt reduced to US$0.9 billion; cash balance at US$5.1 billion.

What else do investors need to know?

Fortescue achieved record iron ore shipments of 201.3 million tonnes, supported by ongoing operating excellence and a focus on safety, with a Total Recordable Injury Frequency Rate of 1.3. The company’s Hematite C1 unit cost was US$18.74 per wet metric tonne, within guidance despite higher energy prices.

Fortescue advanced its Green Grid strategy, progressing renewable energy projects and installing over 300,000 solar panels in the Pilbara. The company also completed the acquisition of Alta Copper, expanding its copper portfolio in Peru.

Ongoing investments in technology, including artificial intelligence for operations and energy management, are intended to boost productivity and long-term cost competitiveness.

What did Fortescue management say?

Fortescue Metals and Operations CEO Dino Otranto said:

Our record operating performance this year underpinned a nine per cent increase in Underlying EBITDA and a 25 per cent increase in free cash flow. We invested US$3.6 billion across the business and finished the year with US$5.1 billion in cash and net debt of just US$0.9 billion. That puts us in a strong position to continue investing in growth while delivering returns to shareholders.

What’s next for Fortescue?

Guidance for FY27 includes 197–207 million tonnes of iron ore shipments and a Hematite C1 unit cost between US$20.50 and US$21.75 per wet metric tonne. Planned capital expenditure is up to US$4.7 billion for metals, with an additional US$150 million earmarked for energy investments.

Fortescue will continue developing its renewable Green Grid, expanding exploration efforts, and focusing on autonomous and AI-driven efficiency improvements. The company aims to build on its strong financial position to support future growth across metals and energy.

Fortescue share price snapshot

The Fortescue share price has underperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a decline of around 7%.

View Original Announcement

The post Fortescue hits new records in FY26: profit up, dividends flow appeared first on The Motley Fool Australia.

More reading

• How much passive income could I earn from a $630,000 superannuation balance?
• How much do I need in my superannuation to earn $50,000 per year in passive income?
• Reporting season half-time report: 5 lessons from August so far
• If I invest $10,000 in Fortescue shares, how much passive income will I receive in 2027?
• How much is needed in superannuation for $2,000 in weekly passive income?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.